BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 27212132)

  • 1. Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation.
    Verleden SE; Sacreas A; Vos R; Vanaudenaerde BM; Verleden GM
    Chest; 2016 Jul; 150(1):219-25. PubMed ID: 27212132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchiolitis obliterans following lung transplantation.
    Al-Githmi I; Batawil N; Shigemura N; Hsin M; Lee TW; He GW; Yim A
    Eur J Cardiothorac Surg; 2006 Dec; 30(6):846-51. PubMed ID: 17055283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
    Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
    Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
    Verleden GM; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Verleden SE; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transpl Int; 2009 Aug; 22(8):771-9. PubMed ID: 19490538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation.
    Todd JL; Palmer SM
    Chest; 2011 Aug; 140(2):502-508. PubMed ID: 21813529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we near to an effective drug treatment for bronchiolitis obliterans?
    Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE
    Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.
    Verleden SE; Vos R; Vandermeulen E; Ruttens D; Bellon H; Heigl T; Van Raemdonck DE; Verleden GM; Lama V; Ross BD; Galbán CJ; Vanaudenaerde BM
    Am J Transplant; 2016 Nov; 16(11):3262-3269. PubMed ID: 27367568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obliterative Bronchiolitis.
    Aguilar PR; Michelson AP; Isakow W
    Transplantation; 2016 Feb; 100(2):272-83. PubMed ID: 26335918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D; Davis RD; Palmer SM
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lung allograft dysfunction after lung transplantation: the moving target.
    Sato M
    Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictors for the Bronchiolitis Obliterans Syndrome in Lung Transplant Patient].
    Yang S; Abuduwufuer A; Lv W; Bao F; Hu J
    Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):496-502. PubMed ID: 32517455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.
    Cooper JD; Billingham M; Egan T; Hertz MI; Higenbottam T; Lynch J; Mauer J; Paradis I; Patterson GA; Smith C
    J Heart Lung Transplant; 1993; 12(5):713-6. PubMed ID: 8241207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
    Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation.
    Jaramillo A; Fernández FG; Kuo EY; Trulock EP; Patterson GA; Mohanakumar T
    Pediatr Transplant; 2005 Feb; 9(1):84-93. PubMed ID: 15667618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
    Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM
    Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lung allograft rejection: mechanisms and therapy.
    Belperio JA; Weigt SS; Fishbein MC; Lynch JP
    Proc Am Thorac Soc; 2009 Jan; 6(1):108-21. PubMed ID: 19131536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey.
    Kapila A; Baz MA; Valentine VG; Bhorade SM;
    J Heart Lung Transplant; 2015 Jan; 34(1):65-74. PubMed ID: 25447585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung transplantation. Bronchiolitis obliterans syndrome.
    Corris PA
    Chest Surg Clin N Am; 2003 Aug; 13(3):543-57. PubMed ID: 13678312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.